Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université du Québec à Montréal

$17,500.00

Interaction between the endocannabinoid system and inflamm-aging : implication in accelerated atherosclerosis in people living with HIV under ART

EF 2022-23

Résumé
Despite the success of antiretroviral treatments (ART) to inhibit HIV viral replication, this infection remains incurable. Thus, people living with HIV (PLWH) suffer from chronic immune dysfunction and persistent inflammation, which lead to accelerated aging (inflamm-aging) and increased risk of comorbidities, such as cardiovascular diseases. Atherosclerosis is a chronic inflammatory disease of the artery wall that obstructs blood flow. In North America, with a prevalence of accelerated atherosclerosis twice as high among PLWH, this disease represents the second source of their mortality. In human physiology, the endocannabinoid system (eCB) is involved in the regulation of metabolism and insures overall homeostasis through its pro- and anti-inflammatory functions. The eCB includes the eCBs anandamide and 2-arachidonoylglycerol and their major receptors, CB1 and CB2, which may play opposite roles in chronic inflammation. Importantly, the eCB is a key regulator of cardiovascular functions and differs based on sex and age. The high expression of CB1 and CB2 receptors in atherosclerotic plaques underscores the importance of the eCB in atherosclerosis. Yet, the role of the eCB in HIV-associated inflamm-aging and comorbidities remains unknown. We aim to characterize the interplay between eCBs and chronic cellular and systemic inflammation in PLWH with or without atherosclerosis compared to uninfected controls. These findings will enable us to determine whether there are changes in the eCB and whether these are associated with alterations in markers of chronic inflammation. If disturbances within the eCB are confirmed in PLWH, interventions aimed at targeting pathways involved in this system will be investigated in future clinical trials.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486649
Name
Comeau Ève
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Interaction between the endocannabinoid system and inflamm-aging : implication in accelerated atherosclerosis in people living with HIV under ART
Programtype2
Studentship Programs
Orgnameinp2
Université du Québec à Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atherosclerosis; Chronic Inflammation; Endocannabinoid System; Flow Cytometry; High Performance Liquid Chromatography; Human Immunodeficiency Virus (Hiv); Inflamm-Aging; Luminex
Abstract
Despite the success of antiretroviral treatments (ART) to inhibit HIV viral replication, this infection remains incurable. Thus, people living with HIV (PLWH) suffer from chronic immune dysfunction and persistent inflammation, which lead to accelerated aging (inflamm-aging) and increased risk of comorbidities, such as cardiovascular diseases. Atherosclerosis is a chronic inflammatory disease of the artery wall that obstructs blood flow. In North America, with a prevalence of accelerated atherosclerosis twice as high among PLWH, this disease represents the second source of their mortality. In human physiology, the endocannabinoid system (eCB) is involved in the regulation of metabolism and insures overall homeostasis through its pro- and anti-inflammatory functions. The eCB includes the eCBs anandamide and 2-arachidonoylglycerol and their major receptors, CB1 and CB2, which may play opposite roles in chronic inflammation. Importantly, the eCB is a key regulator of cardiovascular functions and differs based on sex and age. The high expression of CB1 and CB2 receptors in atherosclerotic plaques underscores the importance of the eCB in atherosclerosis. Yet, the role of the eCB in HIV-associated inflamm-aging and comorbidities remains unknown. We aim to characterize the interplay between eCBs and chronic cellular and systemic inflammation in PLWH with or without atherosclerosis compared to uninfected controls. These findings will enable us to determine whether there are changes in the eCB and whether these are associated with alterations in markers of chronic inflammation. If disturbances within the eCB are confirmed in PLWH, interventions aimed at targeting pathways involved in this system will be investigated in future clinical trials.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Comeau, Ève
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~